Table 2.
Underlying disease and indication for PCC treatment (n = 30)
| n | % | |
|---|---|---|
| Underlying disease | ||
| Liver abscess | 5 | 16.7 |
| Liver cirrhosis | 11 | 36.7 |
| Liver cirrhosis and abscess | 1 | 3.3 |
| Liver cirrhosis and choledocholithiasis | 1 | 3.3 |
| Liver cirrhosis and hepatocellular carcinoma | 1 | 3.3 |
| Hepatocellular carcinoma | 1 | 3.3 |
| Other cancers with jaundice/liver metastasis | 4 | 13.3 |
| Choledocholithiasis with obstructive jaundice | 1 | 3.3 |
| Pelvic inflammatory disease and appendiceal abscess | 1 | 3.3 |
| Acute-on-chronic liver failure (due to autoimmune hepatitis) | 1 | 3.3 |
| Cholangitis and acute kidney injury | 1 | 3.3 |
| Autoimmune hepatitis with jaundice | 2 | 6.7 |
| Indication for PCC treatment | ||
| Abscess aspiration | 5 | 16.7 |
| Large-volume abdominal paracentesis | 1 | 3.3 |
| Other hepatobiliary procedures (ERCP, PTBD) | 8 | 26.7 |
| Gastrointestinal bleeding | 9 | 30.0 |
| Liver biopsy | 3 | 10.0 |
| Open surgery | 3 | 10.0 |
| Laparoscopic surgery | 1 | 3.3 |
ERCP = Endoscopic retrograde cholangiopancreatography; PTBD = percutaneous transhepatic biliary drainage.